LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_002691.4:c.3218+4T>C
POLD1
· NP_002682.2:p.?
· NM_002691.4
GRCh37: chr19:50920530 T>C
·
GRCh38: chr19:50417273 T>C
Gene:
POLD1
Transcript:
NM_002691.4
Final call
VUS
PM2 supporting
BP4 supporting
Variant details
Gene
POLD1
Transcript
NM_002691.4
Protein
NP_002682.2:p.?
gnomAD AF
6.312549474606508e-06 (v4.1)
ClinVar
Uncertain significance
OncoKB
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PM2 supporting: gnomAD v4.1 total allele frequency is 6.31e-06 (10/1,584,146 alleles, zero homozygotes) and the variant is absent from gnomAD v2.1.
2
BP4 supporting: SpliceAI maximum delta 0.025 is below the 0.1 threshold, so no splice-altering effect is predicted for this intronic donor +4 change.
3
VUS: one supporting pathogenic criterion plus one supporting benign criterion satisfies no ACMG/AMP 2015 combination rule.
Final determination:
Under the generic ACMG/AMP 2015 rules, one supporting pathogenic criterion (PM2) together with one supporting benign criterion (BP4) satisfies no Pathogenic, Likely Pathogenic, Benign or Likely Benign combination, so the variant is classified as Variant of Uncertain Significance.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Not met | Not met: c.3218+4T>C lies outside the canonical +/-1,2 donor site and SpliceAI max delta 0.025 predicts no aberrant splicing. |
spliceai
pvs1_variant_assessment
pvs1_generic_framework
pvs1_gene_context
clinvar
|
| PS1 | N/A | Not applicable: c.3218+4T>C is intronic with protein consequence p.?, producing no amino-acid change for a same-change comparison. |
final_classification_framework
clinvar
pm5_candidates
PMID:25394175
|
| PS2 | Not assessed | Not assessed: no proband, parental testing, or pedigree data exists, so a confirmed de novo occurrence cannot be evaluated. |
clinvar
|
| PS3 | Not met | Not met: no functional assay of c.3218+4T>C exists - neither ClinVar submitter nor any retrieved full text reports a splice or protein-function study. |
clinvar
final_classification_framework
PMID:17576681
PMID:9536098
PMID:25394175
|
| PS4 | Not met | Not met: no case-control or cohort enrichment data exists for this variant, and no numeric PS4 threshold is available to compare against. |
clinvar
gnomad_v4
PMID:25394175
|
| PM1 | N/A | Not applicable: c.3218+4T>C is intronic with protein consequence p.? and no occupied domain, and POLD1 has no VCEP domain table. |
final_classification_framework
pvs1_variant_assessment
pm5_candidates
clinvar
|
| PM2 | Met | Met (supporting): gnomAD v4.1 all-comers AF 6.31e-06 (10/1,584,146 alleles, 0 homozygotes) and absent from v2.1, about 16-fold below the 0.0001 PM2 threshold. |
gnomad_v4
gnomad_v2
clinvar
generic_acmg_combination_rules
|
| PM3 | N/A | Not applicable: POLD1 cancer predisposition is autosomal dominant (heterozygous loss-of-function), so the recessive in-trans PM3 criterion does not apply. |
clinvar
oncokb
final_classification_framework
|
| PM4 | Not met | Not met: this intronic substitution is not an in-frame indel or stop-loss, and SpliceAI 0.025 predicts no length-altering exon skipping. |
spliceai
pvs1_variant_assessment
clinvar
|
| PM5 | N/A | Not applicable: c.3218+4T>C is intronic with protein consequence p.?, so no residue exists and no same-residue comparator can be defined. |
pm5_candidates
final_classification_framework
clinvar
PMID:25394175
|
| PM6 | Not assessed | Not assessed: with no proband or parental data, neither confirmed nor assumed de novo status can be established for this variant. |
clinvar
|
| PP1 | Not assessed | Not assessed: no pedigree, affected relatives, or genotype data, so PP1 co-segregation and meioses cannot be counted. |
clinvar
|
| PP2 | N/A | Not applicable: c.3218+4T>C is intronic with protein consequence p.?, not a missense variant, so this missense-specific gene criterion cannot apply. |
final_classification_framework
pvs1_gene_context
pm5_candidates
|
| PP3 | Not met | Not met: SpliceAI max delta 0.025 falls below the 0.2 supporting threshold for PP3. |
spliceai
|
| PP4 | Not assessed | Not assessed: no proband phenotype or family history is recorded anywhere in this case, so phenotype specificity for POLD1 disease cannot be judged. |
clinvar
pvs1_gene_context
|
| PP5 | Not met | Not met: the only ClinVar submissions for this exact variant are two clinical-laboratory Uncertain significance calls with zero expert-panel submissions. |
clinvar
final_classification_framework
|
| BA1 | Not met | Not met: gnomAD v4.1 all-comers AF 6.31e-06 (10/1,584,146 alleles), roughly four orders of magnitude below the 0.05 BA1 threshold. |
gnomad_v4
gnomad_v2
generic_acmg_combination_rules
|
| BS1 | Not met | Not met: gnomAD v4.1 AF 6.31e-06 versus the 0.01 BS1 threshold, roughly 1,500-fold below even using the highest-ancestry estimate. |
gnomad_v4
gnomad_v2
generic_acmg_combination_rules
|
| BS2 | Not met | Not met: zero homozygotes in gnomAD v4.1 (10/1,584,146 alleles) and POLD1 disease is adult-onset, incompletely penetrant cancer predisposition, so BS2's premise fails. |
gnomad_v4
clinvar
generic_acmg_combination_rules
|
| BS3 | Not met | Not met: no functional study of c.3218+4T>C reports normal splicing or protein function; SpliceAI 0.025 is computational, not assay, evidence. |
clinvar
final_classification_framework
PMID:17576681
PMID:9536098
PMID:25394175
|
| BS4 | Not assessed | Not assessed: no family genotype data exists, so non-segregation cannot be demonstrated in this variant's relatives. |
clinvar
|
| BP1 | N/A | Not applicable: c.3218+4T>C is intronic with protein consequence p.?, not a missense variant, so the missense-specific BP1 cannot apply. |
final_classification_framework
pvs1_gene_context
|
| BP2 | Not met | Not met: no phase data exist, so c.3218+4T>C was never observed in cis or in trans with a pathogenic POLD1 variant. |
clinvar
final_classification_framework
|
| BP3 | N/A | Not applicable: BP3 covers in-frame indels in repeat regions, while this is a single-nucleotide intronic donor-site substitution. |
pvs1_variant_assessment
spliceai
|
| BP4 | Met | Met at supporting: SpliceAI max delta 0.025 is at or below the 0.1 splice-impact BP4 threshold. |
spliceai
|
| BP5 | Not assessed | Not assessed: the case has no proband molecular or clinical data, so no alternate molecular basis for disease can be evaluated for BP5. |
clinvar
|
| BP6 | Not met | Not met: no expert-panel Benign/Likely benign classification exists for this exact variant, whose ClinVar entries are both Uncertain significance. |
clinvar
final_classification_framework
|
| BP7 | N/A | Not applicable: c.3218+4T>C is an intronic donor-site change, not a synonymous variant. |
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.